Singapore, March 6 -- Sanofi intends to utilize the net proceeds from the offering for general corporate purposes, supporting its ongoing operational and strategic initiatives.

The transaction was led by Deutsche Bank and J.P. Morgan as Global Coordinators, with ING, Santander CIB, and UniCredit acting as Joint Lead Managers.

Published by HT Digital Content Services with permission from BioSpectrum Asia....